We Are One Seven LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 3,998 shares of the company’s stock, valued at approximately $339,000.

Other hedge funds have also recently modified their holdings of the company. FMR LLC grew its holdings in shares of Henry Schein by 167.3% during the second quarter. FMR LLC now owns 6,632,783 shares of the company’s stock worth $481,805,000 after buying an additional 4,151,179 shares during the last quarter. Select Equity Group L.P. grew its holdings in shares of Henry Schein by 68.2% during the first quarter. Select Equity Group L.P. now owns 6,476,540 shares of the company’s stock worth $435,288,000 after buying an additional 2,625,408 shares during the last quarter. Point72 Asset Management L.P. grew its holdings in shares of Henry Schein by 2,573.5% during the second quarter. Point72 Asset Management L.P. now owns 802,047 shares of the company’s stock worth $58,261,000 after buying an additional 772,047 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Henry Schein by 21.2% during the second quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock worth $159,202,000 after buying an additional 383,479 shares during the last quarter. Finally, Glenmede Trust Co. NA grew its holdings in shares of Henry Schein by 11,084.6% during the second quarter. Glenmede Trust Co. NA now owns 355,000 shares of the company’s stock worth $25,787,000 after buying an additional 351,826 shares during the last quarter. 96.65% of the stock is currently owned by institutional investors.

Shares of NASDAQ:HSIC opened at $83.95 on Friday. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.29 and a quick ratio of 0.68. The stock has a market capitalization of $13.02 billion, a P/E ratio of 23.32, a PEG ratio of 2.45 and a beta of 0.97. Henry Schein, Inc. has a 52 week low of $62.56 and a 52 week high of $90.52.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, August 6th. The company reported $1.04 EPS for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.03. The firm had revenue of $3.33 billion during the quarter, compared to the consensus estimate of $3.31 billion. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.88 earnings per share. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.12 earnings per share for the current fiscal year.

A number of equities analysts recently issued reports on the company. BidaskClub lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, August 30th. Barrington Research reissued a “buy” rating and set a $92.00 price target on shares of Henry Schein in a report on Tuesday, August 7th. ValuEngine raised Henry Schein from a “strong sell” rating to a “sell” rating in a report on Thursday, September 13th. Stifel Nicolaus raised their price target on Henry Schein from $76.00 to $81.00 and gave the stock a “hold” rating in a report on Tuesday, August 7th. Finally, Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $86.00 price target on the stock in a report on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $83.83.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also: Short Selling – Explanation For Shorting Stocks

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.